Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Shares Up 0.3% - Still a Buy?

Shares of Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC - Get Free Report) shot up 0.3% on Wednesday . The stock traded as high as $10.60 and last traded at $10.60. 1,053 shares traded hands during mid-day trading, a decline of 98% from the average session volume of 58,164 shares. The stock had previously closed at $10.57.Analyst Ratings ChangesSeparately, Weiss Ratings restated a "sell (d-)" rating on shares of Oaktree Acquisition Corp. III Life Sciences in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has an average rating of "Sell".View Our Latest Analysis on OACCOaktree Acquisition Corp. III Life Sciences Stock PerformanceThe company's 50 day moving average price is $10.58 and its 200-day moving average price is $10.51. Institutional Inflows and OutflowsA number of institutional investors have recently made changes to their positions in the company. Driehaus Capital Management LLC bought a new position in shares of Oaktree Acquisition Corp. III Life Sciences during the 1st quarter worth $9,180,000. Lighthouse Investment Partners LLC lifted its holdings in Oaktree Acquisition Corp. III Life Sciences by 88.9% during the second quarter. Lighthouse Investment Partners LLC now owns 850,000 shares of the company's stock valued at $8,882,000 after purchasing an additional 400,000 shares during the last quarter. Linden Advisors LP bought a new position in Oaktree Acquisition Corp. III Life Sciences during the first quarter worth about $6,120,000. Goldman Sachs Group Inc. purchased a new position in shares of Oaktree Acquisition Corp. III Life Sciences in the first quarter worth about $5,417,000. Finally, Moore Capital Management LP bought a new stake in shares of Oaktree Acquisition Corp. III Life Sciences in the second quarter valued at approximately $5,502,000. About Oaktree Acquisition Corp. III Life Sciences (Get Free Report)Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.Further ReadingFive stocks we like better than Oaktree Acquisition Corp. III Life Sciences5 discounted opportunities for dividend growth investorsMarket Momentum: 3 Stocks Poised for Major BreakoutsWhat Are Dividend Challengers?3 Reasons Casey’s General Stores Will Continue Trending HigherTrading Halts ExplainedGolden Cross Alert: 3 Stocks With Major Upside PotentialThis instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in Oaktree Acquisition Corp. III Life Sciences Right Now?Before you consider Oaktree Acquisition Corp. III Life Sciences, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oaktree Acquisition Corp. III Life Sciences wasn't on the list.While Oaktree Acquisition Corp. III Life Sciences currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here